Slingshot members are tracking this event:

Arrowhead (ARWR) Has Regulatory Submissions Planned for Phase 1/2 Trial Evaluating ARC-521 in Hepatitis-B by End of Q2 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 28, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Regulatory Submissions